oral semaglutide efficacy variables. 0.5 mg once weekly and 1.0 mg once Suitability and Usefulness of a

However, when combined with other medications that affect blood glucose, particularly insulin or sulfonylureas, the risk of hypoglycemia increases substantially

& Moellering, R

BMJ (Clin Res ed)

Rapid weight loss is an established precipitant of hepatic decompensation in the post bariatric surgery population[3], with pathophysiological mechanisms thought to involve endogenous free-fatty acid oxidative damage, mitochondrial dysfunction and gut dysbiosis leading to hepatic inflammation and fibrosis[4-6]

The company analyzed GLP-1 benefits and access for its patient population and found that currently 69% do not have coverage for this class of drugs to treat diabetes or for weight loss, a significant decline in coverage in the past seven months